Evidence map›Paper›PMID 29194114›Full record

ArticleAIDS (London, England)2018

HIV-1 and hepatitis C virus selection bottleneck in Chinese people who inject drugs.

Fan Li, Liying Ma, Yi Feng, Yuhua Ruan, Jing Hu, Hongshuo Song, Pengtao Liu, Jun Ma, Baolin Rui, Kate Kerpen and 6 more

Abstract read
In one paragraph

Article in AIDS (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 78% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Fan LiState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Liying MaState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Yi FengState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Yuhua RuanState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Jing HuState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Hongshuo SongState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Pengtao LiuState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
Jun MaXinjiang Center for Disease Control and Prevention.
Baolin RuiUrumqi Center for Disease Control and Prevention, Urumqi, China.
Kate KerpenPerelman School of Medicine, University of Pennsylvania.
Benjamin ScheinfeldPerelman School of Medicine, University of Pennsylvania.
Tuhina SrivastavaPerelman School of Medicine, University of Pennsylvania.
David MetzgerPerelman School of Medicine, University of Pennsylvania.
Hui LiPerelman School of Medicine, University of Pennsylvania.
Katharine J BarPerelman School of Medicine, University of Pennsylvania.
Yiming ShaoState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.
University of Pennsylvania · USCenter for Disease Control · TWChinese Center For Disease Control and Prevention · CNNational Center for AIDS/STD Control and Prevention,China CDC · CNXinjiang Uygur Autonomous Region Disease Prevention and Control Center · CN

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI DAVID S METZGER · 1999 to 2026
$78.6M
The HIV-1 and HCV Transmission Bottleneck in Chinese Injection Drug UsersR01DA037244 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BAR, KATHARINE JUNE · 2013 to 2015
$588k
NIAID NIH HHS P30 AI045008NIDA NIH HHS R01 DA037244
6 · The paper itself

Abstract

objectivesFor both HIV-1 and hepatitis C virus (HCV), assessing the stringency of the transmission process is a scientific priority. Enumerations of transmitted/founder (TF) viruses have shown a strict transmission bottleneck in sexual transmission of HIV-1 and a wide range in the multiplicity of infection in HCV. Here, we aim to determine the stringency of parenteral transmission for HIV-1 and HCV in people who inject drugs (PWID).

designWe used molecular sequencing and several complementary analyses to enumerate the TF HIV-1 and HCV variants in a well described cohort of PWID in Xinjiang, China.

methodsWe performed single genome sequencing of HIV-1 env and 5' half HCV genomes, then applied phylogenetic analysis and validated models of early virus diversification to enumerate TF viruses in 60 PWID. We used multivariate analysis to determine correlates of multivariant transmission (MVT).

resultsWe generated 1070 env region sequences from 33 HIV-1 early infected individuals and 773 5' half region sequences from 27 HCV early infected individuals. We found rates of MVT of 39 and 54%, respectively, for HIV-1 and HCV, with a limited range in the number of TF viruses in both infections. Behavioural characteristics suggested high-risk injection practices and lower risk sexual practices; we did not find an association between any specific behaviours and MVT.

conclusionMVT is frequent in parenteral transmission of both HIV-1 and HCV in Xinjiang PWID, indicating a less stringent transmission process than sexual transmission.

Indexed as

Disease Transmission, InfectiousGenetic VariationAdultAsian PeopleChinaenv Gene Products, Human Immunodeficiency VirusFemaleGenotypeHepacivirusHepatitis CHIV-1HIV InfectionsHumansMalePhylogenyRNA, Viralenv Gene Products, Human Immunodeficiency VirusRNA, Viral

Identifiers

PMID29194114
PMCPMC5765877
OpenAlexW2772302376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.